Samaritan Medical Center is closing its Pain Management Center at the end of February because it’s “not meeting the ...
The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
Understanding the link between weight and arthritis pain could be key to finding relief. Learn how small changes in lifestyle can make a big difference.
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...
The traditional Chinese practice of qigong can effectively alleviate chronic low back pain (CLBP), according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback